HealthPro BioVentures

Healthcare & Life Sciences Investment Banking

HealthPro BioVentures LLC provides strategic advisory and investment banking services to emerging companies in the healthcare and life sciences sectors. Today’s challenging healthcare market is our sole focusOur highly experienced staff is comprised of financial professionals from within both the healthcare investment banking and life sciences communities. HealthPro is prepared to play a vital role in helping you secure the financial support and strategic partners that you need to reach your corporate objectives and to maximize your value. 

Martin Kratchman

CEO & Founder


Mr. Kratchman provides a vast array of advisory and banking services to the Healthcare sector including Capital Formation, Merger & Acquisition and Strategic Licensing and Partnering. He currently acts as advisor and investment banker to both public and private healthcare and life sciences companies in the areas of financial offerings, pipeline enhancement/divestment, business development and corporate restructuring.

Mr. Kratchman has specialized in the Healthcare sector since 1992. His principal role as Managing Director at Paramount BioCapital involved creating and managing an investment banking team focused on mergers and acquisitions in the healthcare sector. He acted as lead banker for Cardiome Pharm Corp.’s (COM, TSE CRME, NASD) acquisition of Paralex, Inc. and Adherex Technologies, Inc.’s (AHX, TSE ADH, AMEX) acquisition of Oxiquant, Inc.

Mr. Kratchman was also involved in the distribution of Paramount BioCapital’s private equity companies in the United States, Canada and Europe, raising over $600 million with his three partners. He was also responsible for the structuring and pricing of private equity offerings for both public and private biotech companies, in raising capital for the Aries Fund, and in assisting biotech companies in their search for new research technologies and therapeutic drugs. He has been a financial consultant to various biotech companies.

Mr. Kratchman has lectured in the United States, Canada and in Europe on venture capital and M&A opportunities in biotech. He has a broad range of experience in investment and commercial banking and trading. Prior to joining Paramount in 1992, Martin spent five years at Chase Manhattan Bank, N.A. marketing global fixed income risk management products to European financial institutions. Prior to Chase Manhattan Bank, he was a Vice President at First Boston Corporation on the derivative products desk. Before holding that position, Martin spent five years at Citicorp, N.A. as head of an arbitrage trading unit in futures and options and as manager of Citicorp’s New York Futures Desk.

M.A. International Finance and Banking, Columbia University
B.A. Philosophy, Brandeis University


Go Back